Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

WHO: Number of dementia sufferers to rise 40% to 78 million by 2030

September 3, 2021 Medical Communications

A new report from the WHO has predicted the number of people suffering from dementia is set to rise by …
News

NICE approves secukinumab for young people with severe plaque psoriasis

September 3, 2021 Medical Communications

NICE has approved secukinumab (Cosentyx) as an option for treating moderate to severe plaque psoriasis in people aged six to …
News

Novartis halts kidney transplant drug trial

September 3, 2021 Medical Communications

Novartis has announced that trials investigating CFZ533 (iscalimab) in kidney transplant patients has been halted after interim data show it …
News
astrazeneca_sign_sky

AstraZeneca’s Ultomiris approved for use on children in EU

September 3, 2021 Medical Communications, Research and Development

AstraZeneca has gained EU approval for its rare blood disorder drug, Ultomiris, for use in children. The drug was developed …
News

US Congress to investigate FDA’s approval of Biogen’s Alzheimer’s drug

September 3, 2021 Medical Communications

The US Congress has requested data and documents from the FDA in relation to its accelerated approval of the controversial …
News

Risk of long COVID halved by vaccines, study finds

September 2, 2021 Medical Communications

Researchers at King’s College London have found that being fully vaccinated against COVID-19 not only cuts the risk of catching …
News

Moderna recall COVID vaccines after stainless steel contaminants found

September 2, 2021 Medical Communications

Moderna and Takeda Pharmaceutical on Wednesday said they are working with Japanese authorities to recall three batches of their COVID-19 …
News

FDA seeks new warnings on arthritis drugs

September 2, 2021 Medical Communications

The FDA has requested that Pfizer, Eli Lilly, and AbbVie include additional warnings on their arthritis drugs about the risks …
News
andrei_r_-_shutterstock_1935537274_720

NICE and Cochrane to collaborate on living recommendations

September 1, 2021 Medical Communications, Research and Development

NICE has announced a collaboration with Cochrane, in which Cochrane will help deliver ‘living’ recommendations across the NICE guideline portfolio. …
News

Viper venom found to inhibit COVID virus from multiplying

September 1, 2021 Medical Communications, Research and Development

Brazilian researchers have found that a molecule in the venom of a jararacussu pit viper can prevent coronavirus reproduction. The …
News
moderna_norwood_plant

Fourth contaminated Moderna vial found in Japan

September 1, 2021 Medical Communications, Research and Development

A fourth contamination case in less than a week in Japan has been reported involving Moderna’s COVID-19 vaccine, which threatens …
News

Blood-clot risk “substantially higher” from COVID than from jabs

August 27, 2021 Medical Communications

The risks of developing a blood clot are “substantially higher” after catching coronavirus than following a COVID vaccine, research shows. …
News

UCB’s bimekizumab granted marketing authorisation by MHRA for plaque psoriasis

August 27, 2021 Medical Communications

UCB’s bimekizumab has been granted marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA)  for the treatment of …
News

NICE rejects combination treatment for multiple myeloma

August 27, 2021 Medical Communications

NICE does not recommend daratumumab (Darzalex, Janssen Cilag), plus bortezomib, thalidomide and dexamethasone, as a treatment option for untreated multiple …
News
artificial_heart

CARMAT’s artificial heart commercially implanted successfully for third time

August 27, 2021 Medical Communications

CARMAT’s artificial heart, Aeson, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, has been …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026